The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review

C Free, G Phillips, L Galli, L Watson, L Felix… - PLoS …, 2013‏ - journals.plos.org
Background Mobile technologies could be a powerful media for providing individual level
support to health care consumers. We conducted a systematic review to assess the …

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

M Barry, F Mulcahy, C Merry, S Gibbons… - Clinical pharmacokinetics, 1999‏ - Springer
There are 3 groups of drugs available for the treatment of patients with HIV disease. These
are the nucleoside reverse transcriptase inhibitors ('nucleoside analogues')[zidovudine …

Changing patterns of mortality across Europe in patients infected with HIV-1

A Mocroft, S Vella, TL Benfield, A Chiesi, V Miller… - The Lancet, 1998‏ - thelancet.com
Background The introduction of combination antiretroviral therapy and protease inhibitors
has led to reports of falling mortality rates among people infected with HIV-1. We examined …

[کتاب][B] HIV and the pathogenesis of AIDS.

JA Levy - 1994‏ - cabidigitallibrary.org
This book grew out of a scientific review, originally published in Microbiological Reviews. It
has been updated and expanded-now citing more than 2100 references (100 pages of the …

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study

M Egger, B Hirschel, P Francioli, P Sudre, M Wirz… - Bmj, 1997‏ - bmj.com
Objectives: To examine trends in disease progression and survival among patients enrolled
in the Swiss HIV cohort study during 1988–96 and to assess the influence of new …

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens

RS Hogg, B Yip, C Kully, KJP Craib… - Cmaj, 1999‏ - Can Med Assoc
BACKGROUND: The efficacy of triple-drug antiretroviral regimens in the treatment of
patients infected with HIV has been established in several randomized clinical trials …

Production of resistant HIV mutants during antiretroviral therapy

RM Ribeiro, S Bonhoeffer - Proceedings of the National …, 2000‏ - National Acad Sciences
HIV drug therapy often fails because of the appearance of multidrug-resistant virus. There
are two possible scenarios for the outgrowth of multidrug-resistant virus in response to …

The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study

AR Tappuni, GJP Fleming - Oral Surgery, Oral Medicine, Oral Pathology …, 2001‏ - Elsevier
Objective: The purpose of this study was to compare the prevalence of oral manifestations in
human immunodeficiency virus (HIV)–infected patients on monotherapy, dual therapy, or …

HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?

M Bower, T Powles, T Newsom-Davis… - JAIDS Journal of …, 2004‏ - journals.lww.com
Background: Highly active antiretroviral therapy (HAART) has reduced the incidence and
improved the survival of patients with Kaposi sarcoma and AIDS-related non-Hodgkin …

Bringing epilepsy out of the shadows: wide treatment gap needs to be reduced

R Kale - Bmj, 1997‏ - bmj.com
The history of epilepsy can be summarised as 4000 years of ignorance, superstition, and
stigma followed by 100 years of knowledge, superstition, and stigma. Knowing that seizures …